Connecting and collaborating: Five years of growing life sciences within London and the greater south east of England.
“We have a thriving digital health community in London and the greater south east and the UK digital health segment employs 11,000 people with a turnover of £1.4 billion. Nearly a quarter of Europe’s advanced therapy medicinal product (ATMP) developers are headquartered in the UK, and we are using licensed cell and gene therapies to treat 100s of patients in UK hospitals. Last year we completed the 100,000 genomes project and, in the next five years, the government will expand it to see 1 million whole genomes sequenced. This makes London the only city in the world fully ready to take on the next life sciences challenges where data meets biology meets AI.”
You can read the full article on the MedCity website here.